ICPT Activist 13D/13G Filings - INTERCEPT PHARMACEUTICALS INC.

Real time Form 13D and 13G transaction reports:

Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Goto Prev, 0, 1

Reported DateTime	Type	Company Symbol	Filed By Symbol	Shares Owned % Owned	Shares Vs. Prev Report	Filing
2021-02-10 11:03 am Purchase	13G	INTERCEPT PHARMACEUTICALS INC. ICPT	VANGUARD GROUP INC	2,828,955 8.57%	532,517 (+23.19%)	View
2021-02-08 10:25 am Sale	13G	INTERCEPT PHARMACEUTICALS INC. ICPT	FMR LLC	3,726,914 11.218%	-1,192,202 (-24.24%)	View
2021-01-29 09:56 am Purchase	13G	INTERCEPT PHARMACEUTICALS INC. ICPT	BlackRock Inc. BLK	2,498,408 7.6%	183,940 (+7.95%)	View
2021-01-13 09:32 am Purchase	13G	INTERCEPT PHARMACEUTICALS INC. ICPT	FIRST TRUST PORTFOLIOS LP	1,975,601 5.99%	1,975,601 (New Position)	View
2020-08-31 4:30 pm Sale	13G	INTERCEPT PHARMACEUTICALS INC. ICPT	Genextra S.p.A.	4,031,994 12.2%	-1,500,000 (-27.11%)	View
2020-05-15 5:24 pm Sale	13G	INTERCEPT PHARMACEUTICALS INC. ICPT	Genextra S.p.A.	5,531,994 16.8%	-591,834 (-9.66%)	View
2020-02-12 11:08 am Purchase	13G	INTERCEPT PHARMACEUTICALS INC. ICPT	VANGUARD GROUP INC	2,296,438 7.01%	289,816 (+14.44%)	View
2020-02-10 07:32 am Purchase	13G	INTERCEPT PHARMACEUTICALS INC. ICPT	BlackRock Inc. BLK	2,314,468 7.1%	282,181 (+13.88%)	View
2020-02-07 11:22 am Purchase	13G	INTERCEPT PHARMACEUTICALS INC. ICPT	FMR LLC	4,919,116 14.999%	470,946 (+10.59%)	View
2019-07-31 4:30 pm Purchase	13G	INTERCEPT PHARMACEUTICALS INC. ICPT	Genextra S.p.A.	6,123,828 20.6%	28,250 (+0.46%)	View

Goto Prev, 0, 1